You're right.
It's a double-blinded study.
I.e. clinic and handlers don't know the batches.
It seems insane they got it wrong, but looking at the data it's VERY similar if you just swap it around. That would make the most sense at this point.
- Forums
- ASX - By Stock
- Ann: BTX 1503 Acne Phase 2 Study Results Presentation
You're right. It's a double-blinded study. I.e. clinic and...
-
- There are more pages in this discussion • 403 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
31.5¢ |
Change
-0.030(8.70%) |
Mkt cap ! $570.1M |
Open | High | Low | Value | Volume |
34.5¢ | 34.5¢ | 31.5¢ | $6.354M | 19.19M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 286322 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 28500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 180009 | 0.315 |
18 | 612167 | 0.310 |
25 | 707775 | 0.305 |
48 | 1182708 | 0.300 |
7 | 285599 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 28500 | 1 |
0.325 | 165000 | 4 |
0.330 | 288879 | 4 |
0.335 | 197222 | 4 |
0.340 | 394838 | 8 |
Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online